The Patent Finder
US

Egg Protein Formulations and Methods of Manufacture Thereof

US 10,918,676 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Aimmune Therapeutics, Inc., an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Aug 25, 2035 · High confidence

Filed Apr 26, 2019 as application 16/396,493 · Granted Feb 16, 2021
Base term, 20 years from filing
Today
20 years from filing
2015 2035
Clock starts
Aug 25, 2015
Term ends
Aug 25, 2035
Granted
Feb 16, 2021
base term fee events Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Aug 25, 2015, when application 14/835,336, the earliest non-provisional in its chain, was filed (this one was filed Apr 26, 2019)Aug 25, 2035High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderAug 25, 2035High confidence

This family

US 11,197,896In force
Jul 2038
Jul 2038
US 10,918,676this patent
Aug 2035
Aug 2035
Application 17/454,236Abandoned
not computed
not computed
Application 17/727,679Abandoned
not computed
not computed
US 12,383,584In force
Jun 2036
Jun 2036
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jun 6, 2019
Reel 49398, frame 865
Raff, Howard V.Aimmune Therapeutics, Inc.Assignment of Assignor's Interest
Feb 21, 2022
Reel 59057, frame 590
Aimmune Therapeutics, Inc.Société des Produits Nestlé S.A.Assignment of Assignor's Interest
Aug 11, 2022
Reel 60781, frame 836
Aimmune Therapeutics, Inc.Societe des Produits Nestle S.A.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited